Výsledky vyhledávání

Initial low dose of dacomitinib for first-line treatment of patients with EGFR exon 21 mutated non-small cell lung cancer

Autor: Qinglin Tan, Ningning Guo, Limin Cai, Nianxin Fang, Guanming Jiang, Qinquan Tan, Yanmin Cai, Kejun Liu, Wei Du, Ligang Wu, Lianfu Niu, Jun Jia, Shiyuan Chen

Publikováno v: Journal of Clinical Oncology. 39:e21083-e21083

e21083 Background: Dacomitinib showed superior efficacy for patients with epidermal growth factor receptor (EGFR) sensitive mutations as compared to that of gefitinib, especially for those harboring exon 21 L858R mutation. However, the grade 3-4 trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61397e2755d309bfc49d2c8244f35274
https://doi.org/10.1200/jco.2021.39.15_suppl.e21083

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání